Vyvanse

US allows increased production of Takeda's ADHD drug to address shortage
Reuters
Wed, 09/4/24 - 11:35 am
Takeda
ADHD
Vyvanse
drug shortages
Takeda Lowers Profit Outlook Amid Vyvanse Loss of Exclusivity, Eyes $900M Restructuring in 2024
BioSpace
Thu, 05/9/24 - 11:38 am
Takeda
Vyvanse
exclusivity
Despite Vyvanse's loss of exclusivity, Takeda treads water thanks to launch momentum
Fierce Pharma
Fri, 02/2/24 - 11:43 am
Takeda
ADHD
Vyvanse
earnings
The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023
BioSpace
Wed, 08/23/23 - 11:11 am
patent cliff
patents
Takeda
Vyvanse
Pfizer
Eraxis
JNJ
Stelara
Merck
Isentress
Eiger Pharmaceuticals
Zokinvy
Astellas
Myrbetriq
Novartis
Entresto
Amgen
Otzela
ADHD Medication Shortage Worsens, Vyvanse Supply Dwindles Amid Adderall Scarcity
Yahoo/Benzinga
Thu, 06/22/23 - 11:21 am
ADHD
Vyvanse
drug shortages
Takeda
Takeda, bracing for Vyvanse patent loss, makes strides on debt goal and pivots its focus to launches
Fierce Pharma
Wed, 05/11/22 - 10:49 am
Takeda
debt
Vyvanse
patents
earnings
Some ADHD medicines may increase psychosis more than others, ‘real-world’ data show
Stat
Wed, 03/20/19 - 08:09 pm
ADHD
psychosis
Adderall
Vyvanse
Ritalin
Concerta
14 Drugs Earn Billions for These Massachusetts Biotechs
BioSpace
Wed, 03/6/19 - 09:59 am
Massachusetts
Boston
Biogen
Tecfidera
Benepali
Shire
Takeda
Vyvanse
Vertex Pharmaceuticals
Orkambi
Kalydeco
Alexion
Soliris
Strensiq
Sanofi Genzyme
Lantus
Ironwood Pharmaceuticals
Linzess
New Patent Related Suit Against Shire Could Have Value Into the Billions
CP Wire
Mon, 04/30/18 - 09:39 am
Shire
Vyvanse
fraud
patents
New Patent Related Suit Against Shire Could Have Value Into the Billions
Mon, 04/30/18 - 09:37 am
Shire
Vyvanse
Shire Could Divest ADHD Treatment, Other Assets, for More Upside Post-Baxalta
TheStreet.com
Thu, 07/14/16 - 07:21 pm
Shire
ADHD
Baxalta
Brexit
M&A
Vyvanse
With weight-control peers flailing, Shire keeps growing Vyvanse
Fierce Pharma
Thu, 05/12/16 - 09:43 am
Shire
Vyvanse
obesity
ADHD
With Baxalta in hand, Shire's not looking to buy. But sell? Maybe
Fierce Pharma
Thu, 02/11/16 - 08:59 pm
Baxalta
Shire
M&A
Vyvanse
Shire chalks up victory in Vyvanse patent battle
Fierce Pharma
Fri, 09/25/15 - 08:47 pm
Shire
Vyvanse
patents
ADHD
generics
Vyvanse set to steal ADHD share in back-to-school meds rush
Fierce Pharma Marketing
Wed, 08/19/15 - 12:17 pm
ADHD
Vyvanse
Shire
JNJ
Concerta
Stalwart brands from AZ, Glaxo and Sanofi top ranks of most-prescribed meds
Fierce Pharma
Mon, 08/17/15 - 11:41 am
AstraZeneca
GSK
Sanofi
Advair
Crestor
Lantus
Nexium
Vyvanse
Shire's Vyvanse could bag another lucrative new market in menopausal women
Fierce Pharma Marketing
Tue, 06/16/15 - 12:11 pm
Shire
menopause
Vyvanse
Vyvanse binge eating push, NPS acquisition drives steady Q1 sales for Shire
BioPharma Dive
Tue, 05/5/15 - 05:57 pm
Vyvanse
NPS Pharmaceuticals
Shire
earnings
Shire's binge-eating push on Vyvanse feeds Q1 earnings beat
Fierce Pharma
Thu, 04/30/15 - 02:09 pm
Shire
Vyvanse
earnings
Gulp! A Shire Campaign to Promote Vyvanse for Binge Eating is Questioned
WSJ Pharmalot
Wed, 02/25/15 - 04:18 pm
Shire
binge eating
Vyvanse

Pages